STOCKHOLM, Sept. 24, 2026 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that new clinical data on Gamifant® (emapalumab) in primary haemophagocytic lymphohistiocytosis (HLH) will be presented at the 2026 Annual Meeting of the Histiocyte Society (HS2026), taking place 26-29 September...
Hence then, the article about sobi to present clinical data on gamifant at histiocyte society 2026 in rotterdam was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Sobi to present clinical data on Gamifant® at Histiocyte Society 2026 in Rotterdam )
Also on site :
- Paige DeSorbo on Healing From Domestic Violence With Her Pet: ‘Sometimes the Thing That Helps You Feel Safe Again Has Four Paws’
- Lacey Chabert Has Starred in a Whopping 45 Hallmark Movies: Which Is Her All-Time Favorite? (Exclusive)
- Before Believing Self-Criticism, Try the ‘Friendship Test,’ a Psychotherapist’s Transformative Rule for Fixing Harsh Self-Talk